OptimizeRx (OPRX) Other financing activities (2010 - 2025)

OptimizeRx has disclosed Other financing activities across 8 years of filings, most recently posting $14000.0 for Q4 2025.

• In Q4 2025, Other financing activities changed N/A year-over-year to $14000.0; the TTM figure through Dec 2025 stood at $120000.0 (down 17.81% YoY), while the FY2025 annual figure was $352000.0, changed N/A from the prior year.
• Other financing activities came in at $14000.0 for Q4 2025 at OptimizeRx, up from $1000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.6 million in Q2 2021 to a low of $1000.0 in Q3 2023.
• Average Other financing activities over 4 years is $508142.7, with a median of $238879.0 recorded in 2022.
• Year-over-year, Other financing activities soared 898.65% in 2021 and tumbled 99.54% in 2023.
• Over 4 years, Other financing activities stood at $1.1 million in 2021, then slumped by 97.79% to $23377.0 in 2022, then plunged by 95.72% to $1000.0 in 2023, then soared by 1300.0% to $14000.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $14000.0 in Q4 2025, $1000.0 in Q3 2023, and $105000.0 in Q2 2023.